Company · CIK 0001746466 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Equillium, Inc. · EQ
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 SForm 4 → | Jun 5, 4:42 pm EDT | Christine ZedelmayerSr. Vice President and COO | 14,584 | $2.93 | $42,737 | 62,586 | −18.9% | 10b5-1 |
| Jun 5, 2026 MForm 4 → | Jun 5, 4:42 pm EDT | Christine ZedelmayerSr. Vice President and COO | 14,584 | $0.785 | $11,448 | 77,170 | — | 10b5-1 |
| Jun 4, 2026 SForm 4 → | Jun 5, 4:42 pm EDT | Stephen ConnellyPresident and CSO | 230,975 | $3.13 | $723,830 | 762,025 | −23.3% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 MForm 4 → | Jun 5, 4:42 pm EDT | Christine ZedelmayerSr. Vice President and COO | 14,584 | — | — | 25,521 | — | 10b5-1 |